Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment
Alkermes will present new data for its investigational narcolepsy treatment, ALKS 2680, at SLEEP 2024 in Houston.
Source: sleepreviewmag.com
📰 Michaelj Doane News
Michaelj Doane News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michaelj Doane. Real-time updates on events, politics, business and more.
Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -
Source: finanznachrichten.de